Proposed Data Collections Submitted for Public Comment and Recommendations, 25576-25577 [05-9564]
Download as PDF
<![CDATA[
25576
Federal Register / Vol. 70, No. 92 / Friday, May 13, 2005 / Notices
Dated: May 6, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–9562 Filed 5–12–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–0621]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
2002. The survey was funded by CDC in
2004. The survey covers the following
tobacco-related topics: the prevalence of
use of cigarettes, smokeless tobacco,
cigars, pipe, bidis, and kreteks;
knowledge and attitudes; media and
advertising; minors’ access and
enforcement; school curriculum;
environmental tobacco smoke exposure;
and cessation. Tobacco use, a major
preventable cause of morbidity and
mortality in the U.S., is one of the 28
focus areas in Healthy People 2010.
Within the Healthy People 2010 focus
area of tobacco use, the National Youth
Tobacco Survey provides data relevant
to 6 health objectives. The survey also
provides data to monitor one of the 10
leading health indicators for Healthy
People 2010 that addresses tobacco use.
In addition, the National Youth Tobacco
Survey can identify racial and ethnic
disparities in tobacco-related topics
listed above.
The National Youth Tobacco Survey
is the most comprehensive source of
nationally representative data regarding
high school students and tobacco.
Moreover, the National Youth Tobacco
Survey is the only source of such
national data for middle school students
(grades 6–8). The data have significant
implications for policy and program
development for school health programs
nationwide. There is no other cost to
respondents other than their time.
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Youth Tobacco Survey (OMB
No.: 0920–0621)—Reinstatement with
Change—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The purpose of this request is to
reinstate OMB clearance of the National
Youth Tobacco Survey, a national
school-based study to be conducted in
2006. NCCDPHP wants to continue a
biennial survey among middle and
senior high school students attending
regular public, private, and Catholic
schools in grades 6–12. This survey was
previously funded by the American
Legacy Foundation in 1999, 2000, and
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
(in hours)
Students ...........................................................................................................
School Administrator Arrangements ................................................................
24,500
236
1
1
45/60
30/60
18,375
118
Total ..........................................................................................................
........................
........................
........................
18,493
Dated: May 6, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–9563 Filed 5–12–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
[60Day–05–0680]
Centers for Disease Control and
Prevention
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
VerDate jul<14>2003
15:59 May 12, 2005
Jkt 205001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
E:\FR\FM\13MYN1.SGM
13MYN1
25577
Federal Register / Vol. 70, No. 92 / Friday, May 13, 2005 / Notices
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Model Performance Evaluation
Program (MPEP), Severe Acute
Respiratory Syndrome (SARS) MPEP
OMB No. 0920–0680—Extension—
Division of Laboratory Systems, Center
for Health Information and Services
(CoCHIS), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
To support our mission of improving
public health and preventing disease
through continuously improving
laboratory practices, the Model
Performance Evaluation Program
(MPEP), Division of Laboratory Systems,
Coordinating Center for Health
Information and Services in
collaboration with National Center for
Infectious Disease, Centers for Disease
Control and Prevention intends to
provide a new SARS-associated
Coronavirus testing performance
evaluation program (SARS MPEP). This
program will offer external performance
evaluation (PE) for SARS antibody (Ab)
testing and SARS Ribonucleic Acid
(RNA) Reverse Transcriptase—
Polymerase Chain Reaction (RT–PCR)
testing. A SARS outbreak or epidemic
could recur at any time. Therefore, it is
imperative that the CDC ensure all state
public health department laboratories,
Laboratory Response Network
laboratories and other laboratories
designated by CDC remain proficient in
performing SARS testing. For this
reason, it is of critical public health
importance, at this time, that the CDC
develop and maintain a performance
evaluation program for SARS.
Participation in PE programs is expected
to lead to improved SARS testing
performance because participants have
the opportunity to identify areas for
improvement which will help to ensure
accurate testing as a basis for
development of SARS prevention and
intervention strategies.
This external quality assessment
program will be made available at no
cost (for receipt of sample panels) to 54
state laboratories. This program will
offer laboratories/testing sites an
opportunity for:
(1) Assuring that the laboratories/
testing sites are providing accurate tests
through external quality assessment,
(2) Improving testing quality through
self-evaluation in a nonregulatory
environment,
(3) Testing well characterized samples
from a source outside the test kit
manufacturer,
(4) Discovering potential testing
problems so that laboratories/testing
sites can adjust procedures to eliminate
them,
(5) Comparing individual laboratory/
testing site results to others at state
level, and
(6) Consulting with CDC staff to
discuss testing issues.
Participants in the MPEP SARS will
be required to submit results twice/year
after testing mailed performance
evaluation samples.
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Frequency of
responses
Average
burden per
response
(in hours)
Total burden
(in hours)
SARS Testing Results Booklet ........................................................................
54
2
10/60
18
Total ..........................................................................................................
........................
........................
........................
18
Dated: May 6, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–9564 Filed 5–12–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Preventing
Maternal and Neonatal Bacterial
Infections in Developing Settings with
a High Prevalence of HIV: Assessment
of the Disease Burden and Evaluation
of an Affordable Intervention in
Soweta, South Africa, Request for
Application (RFA) #CI05–059
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
VerDate jul<14>2003
15:59 May 12, 2005
Jkt 205001
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel (SEP): Preventing Maternal and
Neonatal Bacterial Infections in Developing
Settings with a High Prevalence of HIV:
Assessment of the Disease Burden and
Evaluation of an Affordable Intervention in
Soweta, South Africa, Request for
Application (RFA) #CI05–059.
Times and Dates: 9 a.m.-11 a.m., June 3,
2005 (Closed).
Place: Teleconference.
Status: Portions of the meeting will be
closed to the public in accordance with
provisions set forth in section 552b(c)(4) and
(6), Title 5 U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Public Law
92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to: Preventing Maternal and
Neonatal Bacterial Infections in Developing
Settings with a High Prevalence of HIV:
Assessment of the Disease Burden and
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Evaluation of an Affordable Intervention in
Soweta, South Africa, Request for
Application (RFA) #CI05–059.
Contact Person for More Information:
Trudy Messmer, Ph.D., Scientific Review
Administrator, National Center for Infectious
Diseases, CDC, 1600 Clifton Road NE.,
Mailstop C19, Atlanta, GA 30333, Telephone
(404) 639–3770.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 6, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–9554 Filed 5–12–05; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\13MYN1.SGM
13MYN1
]]>Agencies
[Federal Register Volume 70, Number 92 (Friday, May 13, 2005)]
[Notices]
[Pages 25576-25577]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9564]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05-0680]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-371-5983
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c)
[[Page 25577]]
ways to enhance the quality, utility, and clarity of the information to
be collected; and (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology. Written
comments should be received within 60 days of this notice.
Proposed Project
Model Performance Evaluation Program (MPEP), Severe Acute
Respiratory Syndrome (SARS) MPEP OMB No. 0920-0680--Extension--Division
of Laboratory Systems, Center for Health Information and Services
(CoCHIS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
To support our mission of improving public health and preventing
disease through continuously improving laboratory practices, the Model
Performance Evaluation Program (MPEP), Division of Laboratory Systems,
Coordinating Center for Health Information and Services in
collaboration with National Center for Infectious Disease, Centers for
Disease Control and Prevention intends to provide a new SARS-associated
Coronavirus testing performance evaluation program (SARS MPEP). This
program will offer external performance evaluation (PE) for SARS
antibody (Ab) testing and SARS Ribonucleic Acid (RNA) Reverse
Transcriptase--Polymerase Chain Reaction (RT-PCR) testing. A SARS
outbreak or epidemic could recur at any time. Therefore, it is
imperative that the CDC ensure all state public health department
laboratories, Laboratory Response Network laboratories and other
laboratories designated by CDC remain proficient in performing SARS
testing. For this reason, it is of critical public health importance,
at this time, that the CDC develop and maintain a performance
evaluation program for SARS. Participation in PE programs is expected
to lead to improved SARS testing performance because participants have
the opportunity to identify areas for improvement which will help to
ensure accurate testing as a basis for development of SARS prevention
and intervention strategies.
This external quality assessment program will be made available at
no cost (for receipt of sample panels) to 54 state laboratories. This
program will offer laboratories/testing sites an opportunity for:
(1) Assuring that the laboratories/testing sites are providing
accurate tests through external quality assessment,
(2) Improving testing quality through self-evaluation in a
nonregulatory environment,
(3) Testing well characterized samples from a source outside the
test kit manufacturer,
(4) Discovering potential testing problems so that laboratories/
testing sites can adjust procedures to eliminate them,
(5) Comparing individual laboratory/testing site results to others
at state level, and
(6) Consulting with CDC staff to discuss testing issues.
Participants in the MPEP SARS will be required to submit results
twice/year after testing mailed performance evaluation samples.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Frequency of burden per Total burden
Form name respondents responses response (in (in hours)
hours)
----------------------------------------------------------------------------------------------------------------
SARS Testing Results Booklet.................... 54 2 10/60 18
-----------------
Total....................................... .............. .............. .............. 18
----------------------------------------------------------------------------------------------------------------
Dated: May 6, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 05-9564 Filed 5-12-05; 8:45 am]
BILLING CODE 4163-18-P
